Discontinuing disease-modifying therapy in MS after a prolonged relapse-free period: a propensity score-matched study.

Kister I, Spelman T, Alroughani R, Lechner-Scott J, Duquette P, Grand'Maison F, Slee M, Lugaresi A, Barnett M, Grammond P, et al.